
Please try another search
Arbutus Biopharma (NASDAQ:ABUS) reported Q1 EPS of ($0.11), $0.05 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $4.37...
(Reuters) - Alnylam Pharmaceuticals Inc on Thursday filed lawsuits in Delaware federal court against Pfizer Inc (NYSE:PFE) and Moderna (NASDAQ:MRNA) Inc, claiming their multibillion-dollar mRNA...
Investing.com – U.S. stocks were lower after the close on Wednesday, as losses in the Consumer Services, Technology and Telecoms sectors led shares lower. At the close in NYSE, the Dow Jones...
By Yasin Ebrahim Investing.com – The S&P 500 closed lower Wednesday, after cutting its intraday gains as the U.S. confirmed its first case of the new Omicron Covid-19 strain, triggering a fresh wave...
By Yasin Ebrahim Investing.com – The S&P 500 turned negative Wednesday, as investor sentiment was soured by fresh fears about the Omicron coronavirus variant after the U.S. reported its first case of...
By Sam Boughedda Investing.com — Moderna Inc (NASDAQ:MRNA) shares fell Wednesday after the company lost an appeal on a patent ruling involving Arbutus Biopharma Corp (NASDAQ:ABUS). The U.S. Court...
By Brendan Pierson (Reuters) -Moderna Inc could face a patent infringement lawsuit over its COVID-19 vaccine after a federal appeals court on Wednesday rejected its challenge to patents belonging to...
(Reuters) - Moderna Inc (O:MRNA) said there was a possibility it was not the first company to make breakthroughs claimed in its patent applications, including those for its experimental coronavirus...
(Reuters) - Moderna (NASDAQ:MRNA) Inc said on Sunday it has received an additional $472 million from the U.S. government's Biomedical Advanced Research and Development Authority (BARDA) to support...
Investing.com – U.S. stocks were lower after the close on Friday, as losses in the Healthcare, Technology and Industrials sectors led shares lower. At the close in NYSE, the Dow Jones Industrial...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review